TickerFactsScreenerDevelopers

AYTU BIOPHARMA, INC (AYTU) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2022: $44.39M2023: $40.77M2024: $16.13M2025: $20.55M$20.55M
2022Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$20.55M+27.4%
2024$16.13M-60.4%
2023$40.77M-8.2%
2022$44.39M—